+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Finasteride Market by Indication (Androgenetic Alopecia, Benign Prostatic Hyperplasia), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030- Product Image
Global Finasteride Market by Indication (Androgenetic Alopecia, Benign Prostatic Hyperplasia), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030- Product Image
Sale

Global Finasteride Market by Indication (Androgenetic Alopecia, Benign Prostatic Hyperplasia), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967736
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Finasteride Market size was estimated at USD 119.68 million in 2023, USD 122.88 million in 2024, and is expected to grow at a CAGR of 2.81% to reach USD 145.40 million by 2030.

Finasteride is a medication chiefly used in the treatment of benign prostatic hyperplasia (BPH) & male pattern baldness. It operates with conversion of testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss in men. The expansion in the use of finasteride can be attributed to the rising prevalence of these conditions among the aging male population globally. Additionally, increased awareness and social acceptance of seeking treatment for hair loss and prostate health issues have also contributed to its growing use.

However, potential side effects associated with finasteride, such as sexual dysfunction, mood changes, and even a risk of more serious outcomes such as prostate cancer, may hamper the growth of the market. Nevertheless, advancements in personalized medicine tailoring treatment plans to individual genetic profiles could enhance efficacy and reduce side effects, potentially broadening the user base. Additionally, expanding markets in developing countries and further research into other uses of finasteride, such as for hair loss in women, could open new avenues for growth in this sector.

Regional Insights

In the Americas, the primary focus will be on the United States and Canada, which are significant markets for finasteride. In the U.S., the aging population and increasing awareness about male health issues drive the demand for finasteride. Both prescription trends and the presence of major pharmaceutical companies play crucial roles in the market dynamics. Health insurance coverage and the regulatory environment, particularly in terms of drug approval and marketing, also impact the accessibility and usage of finasteride in the region. The market dynamics in Europe are somewhat similar to those in the Americas, with a strong emphasis on healthcare infrastructure and patient accessibility to treatments.

Western Europe, in particular, has a robust market for finasteride due to high awareness levels and substantial healthcare spending. The Asia Pacific region is diverse & rapidly growing, with countries including Japan, Australia, and South Korea having well-developed markets similar to those in the Western world, with strong healthcare systems and high awareness of health issues. Moreover, emerging markets such as China & India are experiencing rapid growth in demand for finasteride. This increase is driven by rising disposable incomes, greater health awareness, and the escalating prevalence of the conditions treated by finasteride.

Market Trends by Segment

  • Indication: High adoption of finasteride in androgenetic alopecia a long-term treatment option
  • Distribution Channel: Emergence of online pharmacies as a convenient option for patients seeking privacy and ease

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Zydus Secures USFDA Approval for Finasteride and Tadalafil Capsules

Zydus Group received the US Food and Drug Administration's final approval to market finasteride and tadalafil capsules. This approval is anticipated to significantly strengthen Zydus's position in the generic pharmaceutical market. The company's success aims at its commitment to making affordable healthcare accessible.

Zydus Lifesciences Expands Its Global Reach with Acquisition of UK-Based Liqmeds Group

Zydus Lifesciences successfully acquired the UK-based pharmaceutical company Liqmeds Group for a transaction valued at USD 82 million. This acquisition aims to enhance Zydus's capabilities in the production and distribution of complex generic products, including liquids and semi-solids. This deal emphasizes Zydus Lifesciences's commitment to becoming a global pharmaceutical leader by integrating innovative strategies and expanding its geographical footprint.

Blue Water Vaccines Acquires Verus Pharmaceuticals’ Entadfi Capsules Division

Blue Water Vaccines, a US-based biopharmaceutical company, successfully acquired the Entadfi capsules business from Verus Pharmaceuticals. This strategic move enhances Blue Water Vaccines' portfolio and marks a significant expansion of its therapeutic offerings in the prostate health sector. This acquisition emphasizes Blue Water Vaccines' commitment to broadening its impact in healthcare, specifically targeting conditions that affect a large demographic of aging men worldwide.

Key Company Profiles

The report delves into recent significant developments in the Finasteride Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare US. by Intas Pharmaceuticals, Apotex Inc., Aurobindo Pharma USA, Inc., Camber Pharmaceuticals, Inc. by Hetero Labs Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo, Inc., Hanmi Pharmaceutical Co., LTD., Merck KGaA, Niksan Life Sciences Private Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Ltd., Veru Inc., Viatris Inc., WELLONA PHARMACEUTICAL PRIVATE LIMITED, and Zydus Group.

This research report offers invaluable insights into various crucial aspects of the Finasteride Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of androgenetic alopecia and prostate disorders
5.1.1.2. Supportive regulatory policies enhancing market accessibility
5.1.2. Restraints
5.1.2.1. Raw material scarcity impacting production scalability
5.1.3. Opportunities
5.1.3.1. Advancements in production technologies for finasteride
5.1.3.2. Significant expansion of finasteride in therapeutic applications
5.1.4. Challenges
5.1.4.1. Shortage of skilled workforce
5.2. Market Segmentation Analysis
5.2.1. Indication: High adoption of finasteride in androgenetic alopecia a long-term treatment option
5.2.2. Distribution Channel: Emergence of online pharmacies as a convenient option for patients seeking privacy and ease
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Finasteride Market, by Indication
6.1. Introduction
6.2. Androgenetic Alopecia
6.3. Benign Prostatic Hyperplasia
7. Finasteride Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies
8. Americas Finasteride Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Finasteride Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Finasteride Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Zydus Secures USFDA Approval for Finasteride and Tadalafil Capsules
11.3.2. Zydus Lifesciences Expands Its Global Reach with Acquisition of UK-Based Liqmeds Group
11.3.3. Blue Water Vaccines Acquires Verus Pharmaceuticals’ Entadfi Capsules Division
11.4. Strategy Analysis & Recommendation
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio
List of Figures
FIGURE 1. FINASTERIDE MARKET RESEARCH PROCESS
FIGURE 2. FINASTERIDE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FINASTERIDE MARKET DYNAMICS
FIGURE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FINASTERIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL FINASTERIDE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 29. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 30. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 33. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 34. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 35. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 36. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 37. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 38. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 39. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 42. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 48. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 57. AUSTRALIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. AUSTRALIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. CHINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. CHINA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. CHINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. CHINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. INDIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 64. INDIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 65. INDIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 66. INDIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. INDONESIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 70. INDONESIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 71. JAPAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. JAPAN FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. JAPAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 74. JAPAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. MALAYSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. MALAYSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. PHILIPPINES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. PHILIPPINES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. SINGAPORE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. SINGAPORE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. SOUTH KOREA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. SOUTH KOREA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. TAIWAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. TAIWAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. THAILAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 96. THAILAND FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 97. THAILAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. THAILAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. VIETNAM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. VIETNAM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. DENMARK FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. DENMARK FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. DENMARK FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 112. DENMARK FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 113. EGYPT FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. EGYPT FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. EGYPT FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. EGYPT FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. FINLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. FINLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. FINLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 120. FINLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 121. FRANCE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. FRANCE FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. FRANCE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. FRANCE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. GERMANY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. GERMANY FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. GERMANY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 128. GERMANY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. ISRAEL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. ISRAEL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. ITALY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. ITALY FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. ITALY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 136. ITALY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. NETHERLANDS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. NETHERLANDS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. NIGERIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 144. NIGERIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 145. NORWAY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. NORWAY FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. NORWAY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 148. NORWAY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 149. POLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. POLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. POLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. POLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. QATAR FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. QATAR FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. QATAR FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 156. QATAR FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 159. RUSSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 160. RUSSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 168. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 169. SPAIN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. SPAIN FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. SPAIN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. SPAIN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. SWEDEN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. SWEDEN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. SWITZERLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 180. SWITZERLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 181. TURKEY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 182. TURKEY FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 183. TURKEY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. TURKEY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 192. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 193. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Accord Healthcare US. by Intas Pharmaceuticals
  • Apotex Inc.
  • Aurobindo Pharma USA, Inc.
  • Camber Pharmaceuticals, Inc. by Hetero Labs Limited
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Endo, Inc.
  • Hanmi Pharmaceutical Co., LTD.
  • Merck KGaA
  • Niksan Life Sciences Private Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals USA, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Veru Inc.
  • Viatris Inc.
  • WELLONA PHARMACEUTICAL PRIVATE LIMITED
  • Zydus Group.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 122.88 Million
Forecasted Market Value ( USD ) by 2030 $ 145.4 Million
Compound Annual Growth Rate2.8%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Global Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Forecast 2024-2030 - Product Image

Global Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Congenital Hyperinsulinism Treatment Market by Indication Type, Treatment, Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030 - Product Image

Global Congenital Hyperinsulinism Treatment Market by Indication Type, Treatment, Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Gout Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Corticosteroids, Colchicine), By Disease Condition (Acute, Chronic), By Distribution Channel, By Region, And Segment Forecasts, 2023-2030 - Product Image

Gout Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Corticosteroids, Colchicine), By Disease Condition (Acute, Chronic), By Distribution Channel, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 100 Pages
  • Global
From
Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2024-2028 - Product Image

Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market 2024-2028

  • Report
  • 174 Pages
  • Global
From
Insulin biosimilars Global Market Report 2024 - Product Image

Insulin biosimilars Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.